The National Institutes of Health (NIH) occasionally send out a solicitation for grants made to encourage studies on a particular topic. In 2007 the NIH issued a request for grant applications that will study the etiology, diagnosis, pathophysiology, and treatment of ME/CFS.
"Chronic Fatigue Syndrome: Pathophysiology and Treatment (R01) --- PA-08-246 --- This Funding Opportunity Announcement (FOA) issued by the Office of Research on Women's Health (ORWH) and co-sponsoring Institutes and Centers (ICs) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME/CFS) in diverse groups and across the lifespan. Innovative applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, and the common mechanisms influencing the multiple body systems that are affected in CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with CFS. http://grants.nih.gov/grants/guide/pa-files/PA-08-246.html
The Participating organizations within the NIH include the following with the exception of the National Institute of Allergy and Infectious Diseases who have announced they will not support clinical trials under this Program Announcement. It is apparent from the Components of Participating Organizations, or lack thereof, that the NIHs desired focus for these grants are NOT centered on finding the cause!
Components of Participating OrganizationsOffice of Research on Women's Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Alternative Medicine
National Institute of Child Health and Human Development
National Institute for Diabetes and Digestive Diseases
National Institute of Dental and Craniofacial Research
Office of Dietary Supplements
National Institute of Environmental Health Sciences
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
■ May 13, 2009 - See Notice NOT-AI-09-042 The National Institute of Allergy and Infectious Diseases (NIAID) will not support clinical trials under this Program Announcement.
Over the last few weeks there has been growing concern about the lack of funding for research in the area of ME/CFS and XMRV. We have heard several times during the CFSAC Meeting and at the 1st International XMRV Workshop that the reason studies are not being done is a direct result of a lack of interest on behalf of researchers. We have been told that grant applications are not being submitted to the NIH to study ME/CFS and XMRV.
However, it has recently come to our attention that the Whittemore Peterson Institute has applied and been turned down for a grant in this area of research SIX TIMES since the publication of the Science paper in 2009. In addition 3 collaborators of WPI have also been denied funding. It is an outrage that the Whittemore Peterson Institute, currently our greatest source of hope for real breakthroughs in neuroimmune disease and XMRV is being shut out.
We would like to encourage every person affected by neuroimmune disease and/or XMRV to contact the National Institutes of Health with your concerns regarding this troubling information.
Secretary Kathleen Sebelius kathleen.sebelius@hhs.gov
Francis Collins collinsf@od.nih.gov
Dennis Mangan dennis.mangan@nih.gov
Anthony Fauci afauci@niaid.nih.gov
Thomas Frieden txf2@cdc.gov
Wanda Jones Wanda.Jones@hhs.gov
"Chronic Fatigue Syndrome: Pathophysiology and Treatment (R01) --- PA-08-246 --- This Funding Opportunity Announcement (FOA) issued by the Office of Research on Women's Health (ORWH) and co-sponsoring Institutes and Centers (ICs) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME/CFS) in diverse groups and across the lifespan. Innovative applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, and the common mechanisms influencing the multiple body systems that are affected in CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with CFS. http://grants.nih.gov/grants/guide/pa-files/PA-08-246.html
The Participating organizations within the NIH include the following with the exception of the National Institute of Allergy and Infectious Diseases who have announced they will not support clinical trials under this Program Announcement. It is apparent from the Components of Participating Organizations, or lack thereof, that the NIHs desired focus for these grants are NOT centered on finding the cause!
Components of Participating OrganizationsOffice of Research on Women's Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Complementary and Alternative Medicine
National Institute of Child Health and Human Development
National Institute for Diabetes and Digestive Diseases
National Institute of Dental and Craniofacial Research
Office of Dietary Supplements
National Institute of Environmental Health Sciences
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
■ May 13, 2009 - See Notice NOT-AI-09-042 The National Institute of Allergy and Infectious Diseases (NIAID) will not support clinical trials under this Program Announcement.
Over the last few weeks there has been growing concern about the lack of funding for research in the area of ME/CFS and XMRV. We have heard several times during the CFSAC Meeting and at the 1st International XMRV Workshop that the reason studies are not being done is a direct result of a lack of interest on behalf of researchers. We have been told that grant applications are not being submitted to the NIH to study ME/CFS and XMRV.
However, it has recently come to our attention that the Whittemore Peterson Institute has applied and been turned down for a grant in this area of research SIX TIMES since the publication of the Science paper in 2009. In addition 3 collaborators of WPI have also been denied funding. It is an outrage that the Whittemore Peterson Institute, currently our greatest source of hope for real breakthroughs in neuroimmune disease and XMRV is being shut out.
We would like to encourage every person affected by neuroimmune disease and/or XMRV to contact the National Institutes of Health with your concerns regarding this troubling information.
Secretary Kathleen Sebelius kathleen.sebelius@hhs.gov
Francis Collins collinsf@od.nih.gov
Dennis Mangan dennis.mangan@nih.gov
Anthony Fauci afauci@niaid.nih.gov
Thomas Frieden txf2@cdc.gov
Wanda Jones Wanda.Jones@hhs.gov